This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Google Scholar Articles by Nichols, W. G. Articles by Boeckh, M. PubMed PubMed Citation Articles by Nichols, W. G. Articles by Boeckh, M.

Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances

GlaxoSmithKline, London, United Kingdom,¹ Program in Infectious Diseases and Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center,² Children's Hospital and Regional Medical Center,³ University of Washington, Seattle, Washington⁴

Summary: Though several antivirals have been developed and marketed to treat influenza virus infections, the development of antiviral agents with clinical activity against other respiratory viruses has been more problematic. Here we review the epidemiology of respiratory viral infections in immunocompetent and immunocompromised hosts, examine the evidence surrounding the currently available antivirals for respiratory viral infections other than influenza, highlight those that are in the pipeline, and discuss the hurdles for development of such agents.